Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Insulet's share price for the quarter that ended in Dec. 2023 was $216.98. Insulet's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 70 Mil. Therefore, Insulet's market cap for the quarter that ended in Dec. 2023 was $15,168 Mil.
Insulet's quarterly market cap
declined
from Jun. 2023 ($20,127 Mil) to Sep. 2023 ($11,137 Mil) but then
increased
from Sep. 2023 ($11,137 Mil) to Dec. 2023 ($15,168 Mil).
Insulet's annual market cap
increased
from Dec. 2021 ($18,406 Mil) to Dec. 2022 ($20,463 Mil) but then
declined
from Dec. 2022 ($20,463 Mil) to Dec. 2023 ($15,168 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Insulet's Enterprise Value for Today is $12,357 Mil.
Insulet Market Cap Historical Data
The historical data trend for Insulet's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Insulet Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Market Cap
10,731.76
16,875.93
18,406.38
20,463.43
15,168.49
Insulet Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Market Cap
20,463.43
22,229.73
20,127.43
11,136.53
15,168.49
Competitive Comparison
For the Medical Devices subindustry, Insulet's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet Market Cap Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Market Cap distribution charts can be found below:
* The bar in red indicates where Insulet's Market Cap falls into.
Insulet Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Insulet's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insulet (NAS:PODD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Insulet Market Cap Related Terms
Thank you for viewing the detailed overview of Insulet's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PODD has been successfully added to your 